Salona Global Medical Device Corporation (LNDZF)
USD 0.08
(0.0%)
USD 0.08
(0.0%)
| Breakdown | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -918.9 Thousand | -993.07 Thousand | -3.7 Million | -975.17 Thousand | -128.04 Thousand | 4 Million |
| Net Income | -15.6 Million | -19.07 Million | -4.37 Million | -2.66 Million | -1.76 Million | -760.56 Thousand |
| Depreciation & Amortization | 2.48 Million | 2.17 Million | 841.76 Thousand | 841.76 Thousand | 54.51 Thousand | 256.03 Thousand |
| Deferred income taxes | -1.77 Million | 604.63 Thousand | -113.63 Thousand | -113.63 Thousand | - | - |
| Stock-based compensation | 1.28 Million | 1.53 Million | 1.19 Million | 237.71 Thousand | 21.96 Thousand | 96.36 Thousand |
| Change in working capital | -924.9 Thousand | 371.59 Thousand | -206.2 Thousand | 1.27 Million | 1.29 Million | 4.34 Million |
| Other non-cash items | 13.6 Million | 13.4 Million | -1.05 Million | -543.84 Thousand | 269.04 Thousand | 61.84 Thousand |
| Investing Cash Flow | -1.51 Million | -6.71 Million | -4.61 Million | 74.87 Thousand | -899.4 Thousand | - |
| Investments in PPE | -203.26 Thousand | -767.36 Thousand | -55.25 Thousand | -55.25 Thousand | - | - |
| Acquisitions | -1.31 Million | -5.65 Million | -5.05 Million | -5.05 Million | - | - |
| Investment purchases | - | - | - | -370.23 Thousand | -899.4 Thousand | - |
| Sales/Maturities of investments | - | - | 496.52 Thousand | 445.1 Thousand | - | - |
| Other Investing Activities | - | -291.84 Thousand | - | 5.11 Million | - | - |
| Financing Cash Flow | 824.54 Thousand | 465.7 Thousand | 3.93 Million | 5.43 Million | - | - |
| Debt repayment | -158.51 Thousand | -1.59 Million | -2.53 Million | -2.53 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 4.26 Million | 4.26 Million | - | - |
| Other Financing Activities | 983.05 Thousand | 2.05 Million | 2.2 Million | 3.7 Million | - | - |
| Accounts receivables | -1.9 Million | - | -2.06 Million | -2.06 Million | - | 1.38 Million |
| Accounts payables | -972.45 Thousand | - | - | - | - | - |
| Inventory | 4.64 Million | -2.13 Million | 248.44 Thousand | 248.44 Thousand | - | - |
| Other working capital | -2.69 Million | 2.51 Million | 1.61 Million | 3.08 Million | 1.29 Million | 2.96 Million |
| Cash at beginning of period | 1.92 Million | 12.5 Million | 12.5 Million | 8.34 Million | 9.3 Million | 6.05 Million |
| Cash at end of period | 918.67 Thousand | 8.05 Million | 8.05 Million | 12.5 Million | 8.34 Million | 9.3 Million |
| Capital Expenditure | -203.26 Thousand | -767.36 Thousand | -55.25 Thousand | -55.25 Thousand | - | - |
| Effect of forex changes on cash | 603.43 Thousand | -110.47 Thousand | -62.77 Thousand | -373.69 Thousand | 72.97 Thousand | -753.86 Thousand |
| Net cash flow / Change in cash | -1 Million | -4.44 Million | -4.44 Million | 4.15 Million | -954.47 Thousand | 3.24 Million |
| Free Cash Flow | -1.12 Million | -1.76 Million | -3.75 Million | -1.03 Million | -128.04 Thousand | 4 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.81 Million | -15.6 Million | 2.98 Million | -1.11 Million | -1.66 Million | -19.07 Million |
| Depreciation & Amortization | -772.17 Thousand | 2.48 Million | 1.18 Million | 1.15 Million | 916.64 Thousand | 2.17 Million |
| Deferred income taxes | 14.2 Million | -1.77 Million | 2546.00 | 23.12 Thousand | - | 604.63 Thousand |
| Stock-based compensation | 286.72 Thousand | 1.28 Million | 264.63 Thousand | 391.57 Thousand | 345.52 Thousand | 1.53 Million |
| Change in working capital | 1.16 Million | -924.9 Thousand | -726.9 Thousand | -635.96 Thousand | -723.28 Thousand | 371.59 Thousand |
| Other non-cash items | 2.04 Million | 13.6 Million | -3.81 Million | -915.75 Thousand | 299.96 Thousand | 13.4 Million |
| Investing Cash Flow | 23.96 Thousand | -1.51 Million | -91.51 Thousand | -1.35 Million | -93.23 Thousand | -6.71 Million |
| Investments in PPE | 23.96 Thousand | -203.26 Thousand | -91.51 Thousand | -42.47 Thousand | -93.23 Thousand | -767.36 Thousand |
| Acquisitions | - | -1.31 Million | - | -1.31 Million | 3363.00 | -5.65 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -3363.00 | -291.84 Thousand |
| Financing Cash Flow | -1.54 Million | 824.54 Thousand | 19.67 Thousand | -229.87 Thousand | 2.57 Million | 465.7 Thousand |
| Debt repayment | -500.7 Thousand | -158.51 Thousand | -164.86 Thousand | -446.03 Thousand | -378.05 Thousand | -1.59 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.04 Million | 983.05 Thousand | 184.54 Thousand | 216.16 Thousand | 2.95 Million | 2.05 Million |
| Accounts receivables | 1.3 Million | -1.9 Million | 1.13 Million | -3.19 Million | -1.14 Million | - |
| Accounts payables | -4.47 Million | -972.45 Thousand | - | - | -513.09 Thousand | - |
| Inventory | 1.4 Million | 4.64 Million | 1.21 Million | 655.42 Thousand | 1.37 Million | -2.13 Million |
| Other working capital | 2.93 Million | -2.69 Million | -3.07 Million | 1.9 Million | -439.57 Thousand | 2.51 Million |
| Cash at beginning of period | 1.05 Million | 1.92 Million | 1.39 Million | 3.69 Million | 1.92 Million | 12.5 Million |
| Cash at end of period | 918.67 Thousand | 918.67 Thousand | 1.05 Million | 1.39 Million | 3.69 Million | 8.05 Million |
| Capital Expenditure | 23.96 Thousand | -203.26 Thousand | -91.51 Thousand | -42.47 Thousand | -93.23 Thousand | -767.36 Thousand |
| Effect of forex changes on cash | 277.15 Thousand | 603.43 Thousand | -167.8 Thousand | 386.25 Thousand | 107.82 Thousand | -110.47 Thousand |
| Net cash flow / Change in cash | -133.96 Thousand | -1 Million | -345.45 Thousand | -2.29 Million | 1.76 Million | -4.44 Million |
| Free Cash Flow | 1.13 Million | -1.12 Million | -197.32 Thousand | -1.13 Million | -917.13 Thousand | -1.76 Million |
300134
PULS
002920
0A26
THNPF
ORGC